Literature DB >> 8395941

Identical APC exon 15 mutations result in a variable phenotype in familial adenomatous polyposis.

P Paul1, T Letteboer, L Gelbert, J Groden, R White, M J Coppes.   

Abstract

Germ-line mutations in the adenomatous polyposis coli (APC) gene result in familial adenomatous polyposis coli (APC), an inherited syndrome that predisposes affected individuals to early onset of colorectal cancer. Somatic APC mutations also have been detected in sporadic colon tumors. We have used single strand conformational polymorphism (SSCP) analysis to scan a region of the APC gene that frequently is mutated in both APC and sporadic colorectal cancer. Four truncating mutations were found between codons 1060 and 1327 in 17 of 68 unrelated APC individuals. Fourteen of these persons carried either of two previously described five-nucleotide deletions which represent about 20% of APC mutations in these pedigrees. Patients with mutations in this region of exon 15 develop a classic APC colonic phenotype with multiple, diffuse adenomas developing by the second or third decade. However, the density of adenomas and the extracolonic disease manifestations associated with this syndrome are variable among individuals with identical APC mutations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395941     DOI: 10.1093/hmg/2.7.925

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  24 in total

Review 1.  [Evaluation of cancer risk through genetic analysis?].

Authors:  A Luz
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

2.  The genetics of inherited colon cancer.

Authors:  Y Wallis; F Macdonald
Journal:  Clin Mol Pathol       Date:  1996-04

3.  Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes.

Authors:  Karla L Otterpohl; Karen A Gould
Journal:  Mamm Genome       Date:  2015-05-15       Impact factor: 2.957

4.  Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families.

Authors:  W Friedl; R Caspari; M Sengteller; S Uhlhaas; C Lamberti; M Jungck; M Kadmon; M Wolf; J Fahnenstich; J Gebert; G Möslein; E Mangold; P Propping
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

5.  Genotype and phenotype factors as determinants for rectal stump cancer in patients with familial adenomatous polyposis. Hereditary Colorectal Tumors Registry.

Authors:  L Bertario; A Russo; P Radice; L Varesco; M Eboli; P Spinelli; A Reyna; P Sala
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

6.  APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis.

Authors:  F M Giardiello; G M Petersen; S Piantadosi; S B Gruber; E I Traboulsi; G J Offerhaus; K Muro; A J Krush; S V Booker; M C Luce; S J Laken; K W Kinzler; B Vogelstein; S R Hamilton
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

7.  Tumor burden and clonality in multiple intestinal neoplasia mouse/normal mouse aggregation chimeras.

Authors:  M R Novelli; H Wasan; I Rosewell; J Bee; I P Tomlinson; N A Wright; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

8.  A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.

Authors:  A R Shoemaker; A R Moser; C A Midgley; L Clipson; M A Newton; W F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.

Authors:  R Fodde; W Edelmann; K Yang; C van Leeuwen; C Carlson; B Renault; C Breukel; E Alt; M Lipkin; P M Khan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Analysis of candidate modifier loci for the severity of colonic familial adenomatous polyposis, with evidence for the importance of the N-acetyl transferases.

Authors:  M D Crabtree; C Fletcher; M Churchman; S V Hodgson; K Neale; R K S Phillips; I P M Tomlinson
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.